The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Major > Johnson & Johnson

Johnson & Johnson
NYSE: JNJ
Change
symbol:
     
 NEWS FROM THE WIRES
Single stock futures make U.S. debut, in theory
Aug 21 2001 03:52 PM PDT

UBS Warburg to provide $2.5 bln to NextWave Telecom
Aug 21 2001 06:57 AM PDT

Guidant gains six months in race for coated stents
Aug 21 2001 06:56 AM PDT

Russia Norilsk Nickel says 95 pct of stock swapped
Aug 21 2001 06:50 AM PDT

Guidant gains six months in race for coated stents
Aug 21 2001 06:49 AM PDT

More WIRE STORIES about this company

 NEWS FROM THE STANDARD
Early Market Movers: Crouching Gladiator
Mar 26 2001 08:57 AM PST

eToys Makes Chapter 11 Filing
Mar 07 2001 10:19 AM PST

News Briefs
Mar 05 2001 12:00 AM PST

EToys Is Giving Up Its BabyCenter
Mar 02 2001 09:54 AM PST

Market Movers: Techs Falling? Try Drugs
Feb 12 2001 02:18 PM PST

 PROFILE
Johnson & Johnson doesn't own your medicine cabinet, it just seems like it. One of the world's largest, most diversified health care product makers, the company operates in three sectors: Consumer products (Tylenol and Motrin analgesics, Reach toothbrushes, Band-Aid bandages); professional products (ACUVUE contact lenses, surgical instruments, joint replacements); and pharmaceuticals (Ergamisol cancer treatment, Ortho-Novum oral contraceptives). The company expands its product line by acquiring or partnering with smaller firms that develop new technologies, to which J&J adds the marketing muscle.

 COMPETITION
Aventis (AVE)
Merck & Co., Inc. (MRK)
The Procter & Gamble Company (PG)

 DEALS
Deal: J&J Combines Forces with Alza
Date Announced: 03.27.01
Value of transaction (US $Mil): 10500
Description: Pharmaceutical research company Alza will merge with Johnson & Johnson in an exchange of stock. Alza will retain its name and management under the J&J umbrella.

Search all deals for this company

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 29,139.00
1-Yr. Sales Growth: 6.1%
Employees: 98,500
Revenue per employee: $295,827.41

 KEY PEOPLE
• Ralph S. Larsen
    CEO
• Robert J. Darretta
    CFO

 CONTACT INFO
1 Johnson & Johnson Plaza
New Brunswick, NJ 08933
US
Phone: 732-524-0400
Fax: 732-524-3300
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001